Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

SJR Rank #4,976H-index: 93SJR: 0.990Best quartile: Q1

Journal website: aims, scope and author guidelines

Publisher

Taylor and Francis Ltd.

Country

United Kingdom

Type

journal

SJR by Edition

Subject Categories

Medicine (miscellaneous)Q1
NeurologyQ2
Neurology (clinical)Q2

Areas: Medicine · Neuroscience

Most published research topics

Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders ResearchParkinson's Disease Mechanisms and TreatmentsGenetic Neurodegenerative DiseasesNeurological diseases and metabolismPrion Diseases and Protein MisfoldingAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesMultiple Sclerosis Research StudiesDysphagia Assessment and Management

Source: OpenAlex

Publication Statistics

Documents per Year

Detailed Information

ISSN

2167-9223, 2167-8421

SJR Best Quartile

Region

Western Europe

Citations per Document (2 years)

2.74

References per Document

32.54

Coverage

2013-2026

Scope

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is an exciting new initiative. It represents a timely expansion of the journal Amyotrophic Lateral Sclerosis in response to the clinical, imaging pathological and genetic overlap between ALS and frontotemporal dementia. The expanded journal provides outstanding coverage of research in a wide range of issues related to motor neuron diseases, especially ALS (Lou Gehrig’s disease) and cognitive decline associated with frontotemporal degeneration. The journal also covers related disorders of the neuroaxis when relevant to these core conditions.

Metrics from SCImago Journal Rank 2025. View on SCImago